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Abstract
We have used the genome-wide marker genotypes from Genetic Analysis Workshop 15 Problem
2 to explore joint evidence for genetic linkage to rheumatoid arthritis across several samples. The
data consisted of four high-density genome scans on samples selected for rheumatoid arthritis. We
cleaned the data, removed intermarker linkage disequilibrium, and assembled the samples onto a
common genetic map using genome sequence positions as a reference for map interpolation. The
individual studies were combined first at the genotype level (mega-analysis) prior to a multipoint
linkage analysis on the combined sample, and second using the genome scan meta-analysis method
after linkage analysis of each sample. The two approaches were compared, and give strong support
to the HLA locus on chromosome 6 as a susceptibility locus. Other regions of interest include loci
on chromosomes 11, 2, and 12.
Background
Problem 2 of Genetic Analysis Workshop 15 (GAW15)
includes genome-wide genotyping of marker sets for link-
age studies in rheumatoid arthritis (RA). Four research
groups contributed sets of markers across the genome gen-
otyped in four independent pedigree samples. NARAC
(North American Rheumatoid Arthritis Consortium) held
by far the largest sample, consisting of multiplex families
genotyped for 10-cM linkage mapping set and a panel of
single-nucleotide polymorphisms (SNPs) genotyped by
Illumina. A Canadian group provided pedigrees geno-
typed for the same Illumina marker panel as well as a
dense 100 k Affymetrix SNP map. ECRAF (European Con-
sortium on Rheumatoid Arthritis Families) genotyped a
dense microsatellite panel. There was also a United King-
dom (UK) data set, comprising both microsatellite and
SNP markers with a two-stage design.
The diversity of these samples and marker maps presents
a complex problem to anyone seeking to merge them in
order to achieve the greater power of a combined sample.
In particular, we were interested in judging whether there
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is a "best" way to merge marker maps, or if available infor-
mation would force one particular solution. We com-
bined the data by placing markers on a common genetic
map and performing linkage analysis on the whole sam-
ple jointly (e.g., McQueen et al. [1]), which we termed a
"mega-analysis". A meta-analysis technique, the genome
scan meta-analysis (GSMA) [2], was used as a comparison
for ease of methodology. This method involves the divi-
sion of the genome into a specific number of fixed-width
"bins", which are then each ranked within a study accord-
ing to the evidence for linkage within the bin (LOD score
or p-value), with a concomitant loss of spatial accuracy.
The GSMA statistic is calculated for each bin as the mean
rank across studies, with significance levels determined by
permutation of the observed ranks within each study.
We were also interested in determining the evidence for
linkage across the genome in each of the four samples
compared with mega-analysis and meta-analysis. The
NARAC sample is considerably larger than the others
(1637 affected individuals versus 118, 187, and 332 in the
Canadian, ECRAF, and UK samples, respectively), and
might be expected to outweigh the others in any joint
analysis.
Methods
Marker maps
Four data sets were analyzed for autosomal genetic link-
age to RA (Table 1). The Canadian Affymetrix genotypes
were excluded owing to difficulties in placing markers and
time considerations. In cases in which several marker sets
were available in the same sample, the most informative
was selected as detailed below.
We assembled all markers from all studies onto a com-
mon centimorgan (cM) genetic map using a procedure
described in Hamshere et al. [3]. Markers that could not
be positioned were removed from the analysis. We were
provided with a genetic and physical sequence (RefSeq)
alignment of the NARAC and ECRAF microsatellite mark-
ers. The base-pair position provided for Illumina SNPs
(NARAC and Canada) did not correspond to the physical
map, and so these markers were queried against the NCBI
database to obtain updated positions comparable with
the NARAC and ECRAF microsatellite positions.
The UK microsatellite positions were judged to be on the
same map as NARAC, on the basis of 19 (out of 20) mic-
rosatellites common to both sets, which had identical cen-
timorgan positions. Because the UK SNP marker map was
of unknown provenance and the marker names cryptic, it
was assumed to be comparable if not identical to the UK
microsatellite map.
Because all other marker sets could be positioned relative
to the NARAC/UK genetic map with a minimum number
of assumptions, this was used as a standard map, and the
NARAC microsatellites were used as reference markers
(RMs). NCBI base-pair positioning permitted the interpo-
lation of all other markers into each RM interval. Markers
positioned outside of this standard map on each chromo-
some were removed from the analyses to prevent the pos-
sibility of negative map positions or overinflated
chromosomal lengths. A total of 517 markers were
removed from the NARAC and Canada SNP maps, and 74
markers from the ECRAF microsatellite map. A high level
of correlation was observed between the original map and
our standard map (interpolated on the basis of sequence
positions) for the ECRAF microsatellites (Pearson r  >
0.99). Of note are three markers which differed consider-
ably in genetic position between the two maps: D9S144,
D12S43, and D16S289 were originally positioned at 0
cM, and shifted by between 20 and 100 cM in the standard
map, due to their current position in the sequence data-
base. These instances were excluded from our analysis,
and should be followed up in order to be sure of the iden-
tity and location of the typed marker.
Data cleaning
All pedigrees were examined for Mendelian inconsisten-
cies using the PedCheck program [4]. The GRR software
[5] was used to detect potential misspecification of
within-family relationships or sample mix-ups, which
were then removed. We screened out pedigrees containing
individuals of non-Caucasian/European ancestry, where
known.
Linkage disequilibrium
Multipoint linkage disequilibrium (LD) was eliminated
from each data set in order to prevent artificial inflation of
the multipoint linkage statistics arising from incorrect
allele frequency estimation in cases of missing parental
Table 1: Descriptions of the data sets
Sample Markers No. Pedigrees (No. affected individuals) No. markers Map
UK SNPs 157 (332) 2473 cM map 1
NARAC Illumina SNPs 725 (1637) 2364 base-pair position
ECRAF Microsatellites 88 (187) 872 cM map 2
Canada Illumina SNPs 59 (118) 2364 base-pair positionBMC Proceedings 2007, 1(Suppl 1):S104 http://www.biomedcentral.com/1753-6561/1/S1/S104
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data [6]. In the first instance, each marker map was
thinned to a minimum intermarker distance of 0.5 cM.
The microsatellite map was adjusted for LD as detailed by
Hamshere et al. [3]. For the SNP markers, pair-wise LD in
founder individuals, or the whole sample if insufficient
founders were genotyped, was measured using LDMAX
[7]. Marker pairs further apart than 5 cM were ignored
because this was felt to be unlikely to affect the multipoint
linkage statistic. A list of marker pairs in LD was compiled
and one marker from the first pair was removed from the
analysis, and the list was updated. The process was
repeated until no marker pairs with r2 > 0.05 remained.
We removed 7683 of the UK SNPs, 2546 of the NARAC
and Canada SNPs, and 88 of the ECRAF microsatellites.
Linkage analysis
Multipoint inkage analysis of the RA binary trait was per-
formed on a 2-cM grid using MERLIN [8], with the 'npl'
and 'exp' options. The average information content was
higher for the UK SNP maps than for the microsatellite
data. The NARAC SNP markers were also typed for a larger
sample than the microsatellites. We used the SNP geno-
types, rather than the microsatellite genotypes, for these
two samples.
Meta-analysis
A GSMA was performed as described previously [2,9]. The
recommended bin boundaries for 120 30-cM bins were
used in order to permit direct comparisons with previous
studies. The bin-boundary markers were interpolated
onto the NARAC genetic map, and all markers were
'binned' by reference to their positions. The maximum
LOD score in each bin was used by the GSMA program to
derive ranks for each bin, weighted by the square root of
the number of affected individuals, and genome-wide sig-
nificance was calculated from 10,000 permutations.
Results and discussion
The maximum LOD score on each chromosome from the
four individual samples are presented in Table 2 alongside
the results of the mega-analysis. Chromosome 6 showed
the highest LOD (20.71) at 46 cM in the mega-analysis, as
well as the highest LOD in each of the individual screens
(with the exception of Canada). It was the only locus with
LOD > 0.5 observed in the UK sample.
High linkage scores were also detected on chromosomes
11 (LOD = 2.81, 48 cM), 2 (LOD = 2.01, 194 cM), and 4
(LOD = 1.83, 110 cM). Loci showing low or modest link-
age with some concordance across studies included chro-
mosomes 9 (136–146 cM), 12 (104–136 cM), and 21
(30–52 cM). Five chromosomes (3, 14, 15, 17, and 22)
showed no LOD score > 1.
The results of the meta-analysis (Table 3) implicate the
same region as the mega-analysis on chromosome 6 as a
Table 2: Maximum linkage score of each chromosome in the four genome screens, and combined analysis
Mega-analysis UK NARAC ECRAF Canada
Chr LOD cM LOD cM LOD cM LOD cM LOD cM
1 1.02a 240 0.44 156 1.28 234 1.69 28 0.57 272
2 2.01 194 0.07 238 3.16 192 2.03 86 0.81 104
3 0.17 64 0.24 118 0.43 78 0.69 146 0.4 54
4 1.83 110 0.01 64 2.77 110 1.16 20 . 2 50
5 1.42 26 0.04 186 3.35 26 0.85 164 0.18 186
6 20.71 46 2.85 58 16 46 2.93 44 1.39 156
7 1.66 126 0.03 84 2.08 1 4 40 . 3 31 4 01.93 34
8 0.72 104 0.33 102 1.16 118 0.2 92 0.73 68
9 0.76 146 0.04 32 0.54 146 0.1 136 2.12 144
10 1.69 102 0.3 154 2.46 90 0.13 102 0.23 6
11 2.81 48 0.01 26 4.02 48 0.01 42 0.53 28
12 1.29 42 0.31 136 1.55 44 1.5 104 1.16 118
13 0.51 80 0.36 80 1.01 28 2.46 102 0.18 92
14 0.27 108 0.36 76 0.67 92 0.16 126 0.33 114
15 0.68 100 -0.01 104 0.7 100 0.21 98 0.48 104
16 1.07 78 0.16 20 1.49 68 0.57 46 0 72
17 0.85 86 0.15 82 0.99 106 0.73 6 0.58 0
18 1.03 76 0 112 0.96 80 0.94 100 0.37 20
19 0.88 96 0.19 86 0.43 98 0.12 56 1.11 102
20 0.37 88 -0.03 98 1.1 86 1.9 40 . 1 6 5 6
21 1.37 42 0.32 52 1.15 42 0.55 40 0.11 30
22 0.24 60 0.03 60 0.2 42 0.71 8 0.02 14
aLOD > 1 highlighted in bold.BMC Proceedings 2007, 1(Suppl 1):S104 http://www.biomedcentral.com/1753-6561/1/S1/S104
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susceptibility locus for RA, with bin 2 achieving genome-
wide significance according to the Lander and Kruglyak
criteria [10], and bins 1 and 3, genome-wide suggestive
linkage. Interestingly, there may be some evidence for a
second locus on chromosome 6. Meta-analysis of bin 5
(centered at ~150 cM) shows low/modest peaks in all the
samples, and covers the location of the highest peak on
the chromosome in the Canadian sample. The mega-anal-
ysis showed a LOD score peak of 2.01 at 148 cM on this
chromosome.
Three of these samples (NARAC, ECRAF, UK) have been
used in previous meta-analyses [11,12]. As in those anal-
yses, we find our most significant results on chromosome
6p, and nominal significance on chromosomes 12p and
2q. Discrepancies such as on chromosomes 8p and 1q
may be attributable to differences in the samples (we
added the Canadian data set and updated versions of the
other data sets; we removed non-Caucasian pedigrees)
and markers (where possible we used SNP markers rather
than microsatellites; we ensured LD was removed prior to
linkage analysis).
Several of these bins span candidate gene loci, including
the HLA-DRB1 locus in bin 6.2. CTLA, which may be a
susceptibility locus for RA [13] is located in bin 2.8, the
second and third most significant chromosome in the
meta- and mega-analysis, respectively. The PTPN22 locus
maps to bin 1.6, which was the 25th highest ranked bin in
the meta-analysis, and was not significant. This locus did
not feature in any of the individual analyses, although the
mega-analysis shows a small peak over the gene locus at
156 cM, with a maximum score of 0.99 (nominal p =
0.02).
The conduct of our study was largely focused on the
details of combining samples for mega-analysis in a rigor-
ous fashion, and we conclude that the process adopted
will often be dictated by the characteristics of the samples,
and the information available on each. Researchers
should follow common sense in including the data that
provide the maximum information for each sample. The
use of commercial high-density SNP maps, and the full-
genome physical maps have made this process easier and
probably more accurate than in the recent past. Meta-
analysis techniques such as GSMA are more straightfor-
ward to perform than a mega-analysis, since they do not
require access to the genotype data. Both the meta- and
mega-analyses detect the strong linkage to chromosome 6.
In addition, regions on chromosomes 2 (194 cM) and 12
(42 cM) are highlighted by both analyses. However, the
mega-analysis showed evidence for linkage to chromo-
somes 10q and 11q, which was not observed in the
GSMA. This is because chromosomes 2 and 12 show con-
sistent linkage evidence across the four samples, whereas
the linkages of chromosomes 10q and 11q are due almost
entirely to high LOD scores from the NARAC sample, with
negligible linkage evidence in the other three samples.
The GSMA assigns significance to regions where linkage
statistics are consistently highly-ranked across studies, but
does not take into account the magnitude of the linkage
statistics. Thus, it will not detect linkages based on a very
high linkage statistic from one sample.
Conclusion
This is the largest combined sample analyzed so far for
linkage to RA. Both meta- and mega-analysis detected a
highly significant linkage to chromosome 6p, with weaker
linkages to chromosomes 6q, 2q, and 12p. In each of
these regions there was consistent linkage evidence across
the four samples. The mega-analysis also detected linkage
to chromosomes 10q and 11q. In these regions, the link-
age evidence came almost entirely from the NARAC sam-
ple, so they were not picked up by the meta-analysis.
When performing an analysis of combined samples, it is
important to ensure that marker maps are compatible,
Table 3: Bins with nominally significant GSMA results
Bin (chr. bin) Position (cM)a Summed rank p-valueb Ordered rank p-value
6.2c 28.4–64.8 1.67 × 10-6d 2.0 × 10-4
6.3 64.8–99.7 0.0005e 0.0016
6.1 0.0–28.4 0.0017e 0.0010
6.5 131.1–166.5 0.0152 0.0932
6.4 99.7–131.1 0.0205 0.0786
2.8 176.0–208.0 0.0270 0.0820
12.2 24.4–51.4 0.0477 0.3382
2.6 128.0–156.0 0.0487 0.1992
acM position according to the NARAC map.
bSR p-value < 0.05
cBold type indicates bins with both SR and OR p-values < 0.05.
dGenome-wide significant
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and that as many genotyping errors as possible are
removed. It is also important to keep inter-marker LD to a
minimum.
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